AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$105,750
+13.7%
Shares
Shares Volume: 75,000 Shares
Average Share Price: $1.41
INSIDER
Readnour Robin Shane
Director
reported on Nov 27 2024
traded on Nov 26 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 622,573 |
| PURCHASES/SALES 1Y | 2 / 2 |
| P/S VALUE RATIO | 2.917 |
| AVERAGE PURCHASE VALUE | $162,875 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 3 / 0 |
| PURCHASES/SALES 1Y | 6 / 11 |
| P/S VALUE RATIO | 0.196 |
| AVERAGE PURCHASE VALUE | $327,258.33 |
| COMPANY PREVIOUS TRADES |